A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
'Dry Liposome Adjuvant-Containing Vaccines And Related Methods Thereof' in Patent Application Approval Process (USPTO 20230060631)
Published:
March 22, 2023
by NewsRx Pharma Business Daily
|
Reuters reports GSK, Moderna, CSL Seqirus all working on bird flu vaccinations for humans focused on currently circulating bird flu subtype; in US, bird flu has killed about 58 million birds, although human cases worldwide have remained very rare
Published:
March 21, 2023
by Medical Daily
|
Patent Application Titled 'Immunogenic Composition' Published Online (USPTO 20230060184)
Published:
March 17, 2023
by NewsRx Pharma Business Daily
|
GSK announces positive results from phase III trial of 5-in-1 meningococcal ABCWY vaccine candidate
Published:
March 15, 2023
by PharmaBiz (India)
|
GSK releases 2022 ESG Performance Report; highlights include 100% of GSK sites meet Alliance for Water Stewardship’s good water steward requirements, GSK reduced scope 1 and 2 operational emissions by 6% from 2021
Published:
March 10, 2023
by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count